Traceable Supply Chain Is “End Game” To Stop Counterfeits, FDA Risk Advisor Says
Executive Summary
FDA’s risk communications cannot outpace counterfeiters, advisory committee member warns, citing the need for more rigorous supply chain controls; meanwhile, agency’s counterfeit drug alerts aimed at physicians draw industry praise.